Market Authorization for Covovax Approved by DCGI


PTI    17 January 2023

On Monday, the Drug Controller General of India approved the market authorization for Covovax as a heterologous booster dose for adults who have completed their primary COVID-19 vaccination schedules. The approval followed the recommendations of the Central Drug Standard Control Organization′s subject expert committee.


The official sources stated that the expert committee held a meeting on Wednesday where they discussed and recommended the market authorization of Covovax for adults who have completed 2 primary doses of Covishield or Covaxin.


Dr. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had previously written a letter to the DCGI seeking approval for administering Covovax as a heterologous booster dose.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.